PlainRecalls
FDA Drug Moderate Class II Terminated

Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5348-01

Reported: August 14, 2013 Initiated: June 18, 2013 #D-849-2013

Product Description

Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5348-01

Reason for Recall

Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.

Details

Units Affected
7,579 bottles
Distribution
Nationwide
Location
Sellersville, PA

Frequently Asked Questions

What product was recalled?
Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5348-01. Recalled by Teva Pharmaceuticals USA, Inc.. Units affected: 7,579 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2013. Severity: Moderate. Recall number: D-849-2013.